BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32943095)

  • 1. Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer's disease.
    Weston PSJ; Poole T; Nicholas JM; Toussaint N; Simpson IJA; Modat M; Ryan NS; Liang Y; Rossor MN; Schott JM; Ourselin S; Zhang H; Fox NC
    Alzheimers Res Ther; 2020 Sep; 12(1):112. PubMed ID: 32943095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.
    Weston PS; Nicholas JM; Lehmann M; Ryan NS; Liang Y; Macpherson K; Modat M; Rossor MN; Schott JM; Ourselin S; Fox NC
    Neurology; 2016 Nov; 87(19):2050-2057. PubMed ID: 27733562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease.
    Vilaplana E; Rodriguez-Vieitez E; Ferreira D; Montal V; Almkvist O; Wall A; Lleó A; Westman E; Graff C; Fortea J; Nordberg A
    Neurology; 2020 May; 94(19):e2026-e2036. PubMed ID: 32291295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers.
    Quiroz YT; Stern CE; Reiman EM; Brickhouse M; Ruiz A; Sperling RA; Lopera F; Dickerson BC
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):556-61. PubMed ID: 23134660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.
    Ringman JM; O'Neill J; Geschwind D; Medina L; Apostolova LG; Rodriguez Y; Schaffer B; Varpetian A; Tseng B; Ortiz F; Fitten J; Cummings JL; Bartzokis G
    Brain; 2007 Jul; 130(Pt 7):1767-76. PubMed ID: 17522104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.
    Weston PSJ; Poole T; Ryan NS; Nair A; Liang Y; Macpherson K; Druyeh R; Malone IB; Ahsan RL; Pemberton H; Klimova J; Mead S; Blennow K; Rossor MN; Schott JM; Zetterberg H; Fox NC
    Neurology; 2017 Nov; 89(21):2167-2175. PubMed ID: 29070659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study.
    Weston PSJ; Nicholas JM; Henley SMD; Liang Y; Macpherson K; Donnachie E; Schott JM; Rossor MN; Crutch SJ; Butler CR; Zeman AZ; Fox NC
    Lancet Neurol; 2018 Feb; 17(2):123-132. PubMed ID: 29413314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [
    O'Connor A; Cash DM; Poole T; Markiewicz PJ; Fraser MR; Malone IB; Jiao J; Weston PSJ; Flores S; Hornbeck R; McDade E; Schöll M; Gordon BA; Bateman RJ; Benzinger TLS; Fox NC
    Alzheimers Res Ther; 2023 May; 15(1):99. PubMed ID: 37231491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
    O'Connor A; Karikari TK; Poole T; Ashton NJ; Lantero Rodriguez J; Khatun A; Swift I; Heslegrave AJ; Abel E; Chung E; Weston PSJ; Pavisic IM; Ryan NS; Barker S; Rossor MN; Polke JM; Frost C; Mead S; Blennow K; Zetterberg H; Fox NC
    Mol Psychiatry; 2021 Oct; 26(10):5967-5976. PubMed ID: 32665603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease.
    Weston PSJ; Poole T; O'Connor A; Heslegrave A; Ryan NS; Liang Y; Druyeh R; Mead S; Blennow K; Schott JM; Frost C; Zetterberg H; Fox NC
    Alzheimers Res Ther; 2019 Feb; 11(1):19. PubMed ID: 30786919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers.
    Fortea J; Sala-Llonch R; Bartrés-Faz D; Bosch B; Lladó A; Bargalló N; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2010; 22(3):909-22. PubMed ID: 20858974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease.
    Ryan NS; Keihaninejad S; Shakespeare TJ; Lehmann M; Crutch SJ; Malone IB; Thornton JS; Mancini L; Hyare H; Yousry T; Ridgway GR; Zhang H; Modat M; Alexander DC; Rossor MN; Ourselin S; Fox NC
    Brain; 2013 May; 136(Pt 5):1399-414. PubMed ID: 23539189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of cortical thinning in familial Alzheimer's disease.
    Knight WD; Kim LG; Douiri A; Frost C; Rossor MN; Fox NC
    Neurobiol Aging; 2011 Oct; 32(10):1765-73. PubMed ID: 20005601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations.
    Lee GJ; Lu PH; Medina LD; Rodriguez-Agudelo Y; Melchor S; Coppola G; Braskie MN; Hua X; Apostolova LG; Leow AD; Thompson PM; Ringman JM
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):154-62. PubMed ID: 23085935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss and dispersion of superficial white matter in Alzheimer's disease: a diffusion MRI study.
    Veale T; Malone IB; Poole T; Parker TD; Slattery CF; Paterson RW; Foulkes AJM; Thomas DL; Schott JM; Zhang H; Fox NC; Cash DM
    Brain Commun; 2021; 3(4):fcab272. PubMed ID: 34859218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gyrification abnormalities in presymptomatic
    Caverzasi E; Battistella G; Chu SA; Rosen H; Zanto TP; Karydas A; Shwe W; Coppola G; Geschwind DH; Rademakers R; Miller BL; Gorno-Tempini ML; Lee SE
    J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):1005-1010. PubMed ID: 31079065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study.
    Cash DM; Ridgway GR; Liang Y; Ryan NS; Kinnunen KM; Yeatman T; Malone IB; Benzinger TL; Jack CR; Thompson PM; Ghetti BF; Saykin AJ; Masters CL; Ringman JM; Salloway SP; Schofield PR; Sperling RA; Cairns NJ; Marcus DS; Xiong C; Bateman RJ; Morris JC; Rossor MN; Ourselin S; Fox NC;
    Neurology; 2013 Oct; 81(16):1425-33. PubMed ID: 24049139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter changes in familial Alzheimer's disease.
    Li X; Westman E; Ståhlbom AK; Thordardottir S; Almkvist O; Blennow K; Wahlund LO; Graff C
    J Intern Med; 2015 Aug; 278(2):211-8. PubMed ID: 25639959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease.
    Apostolova LG; Hwang KS; Medina LD; Green AE; Braskie MN; Dutton RA; Lai J; Geschwind DH; Cummings JL; Thompson PM; Ringman JM
    Dement Geriatr Cogn Disord; 2011; 32(2):118-25. PubMed ID: 21952501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort.
    Prescott JW; Doraiswamy PM; Gamberger D; Benzinger T; Petrella JR;
    Radiology; 2022 Jan; 302(1):143-150. PubMed ID: 34636637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.